032 PADIS FAQ WEB READY v3.indd

First Page		Document Content
Date: 2013-02-12 12:58:30 Pharmacology Neurochemistry Monoamine oxidase inhibitors Entheogens Attention-deficit hyperactivity disorder MDMA Stimulant Effects of MDMA on the human body Recreational drug use Amphetamines Euphoriants Medicine		032 PADIS FAQ WEB READY v3.indd Add to Reading List Source URL: www.albertahealthservices.ca Download Document from Source Website File Size: 1.006,38 KB Share Document on Facebook

	The PROFILE®-III/VERDICT®-III products are one-step qualitative screening assays for the detection of one or more of the following: Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methamphetamine/ 3,4 Methylene DocID: 1vbZz - View Document
	The PROFILE®-III/VERDICT®-III products are one-step qualitative screening assays for the detection of one or more of the following: Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methamphetamine/ 3,4 Methylene DocID: 1uR19 - View Document
	Brit. J. Pharmacol), 24, DIFFERENTIAL EFFECTS OF TWO AMPHETAMINEBARBITURATE MIXTURES IN MAN BY D. W. DICKINS*, M. H. LADERt AND HANNAH STEINBERG DocID: 1s1P0 - View Document
	4 PHARMACOLOGIC TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS DocID: 1r9hg - View Document
	New Drugs Approved in FY 2015 Review Category Approval Date No. DocID: 1r3Vv - View Document